We are live on ! Find out more
Globeflex Capital

Globeflex Capital Portfolio holdings

AUM $783M Turnover 28.73%
1-Year Est. Return 81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
Cap. Flow
-$22.1M
Cap. Flow %
-2.82%
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62
Avg Time Held
1.9 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.4 years

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$6.96M
2
MYRG icon
MYR Group
MYRG
+$4.57M
3
DRS icon
Leonardo DRS
DRS
+$4.16M
4
SMTC icon
Semtech
SMTC
+$3.99M
5
P icon
Everpure Inc
P
+$3.43M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Industrials 19.78%
3 Financials 17.73%
4 Healthcare 17.14%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
UFCS icon
101
United Fire Group
UFCS
$1.46B
$2.3M 0.29%
43,882
+915
+2% +$40.6K
2024 Q4
6 quarters
PGY icon
102
Pagaya Technologies
PGY
$1.6B
$2.24M 0.29%
122,956
+18,191
+17% +$258K
2025 Q2
4 quarters
INTT icon
103
inTEST
INTT
$183M
$2.23M 0.28%
122,730
+4,158
+4% +$70.4K
2025 Q4
2 quarters
INDA icon
104
iShares MSCI India ETF
INDA
$5.86B
$2.14M 0.27%
43,326
-12,317
-22% -$601K
2022 Q3
15 quarters
PAY icon
105
Paymentus
PAY
$4.13B
$2.13M 0.27%
88,313
-1,427
-2% -$35K
2024 Q1
9 quarters
ARW icon
106
Arrow Electronics
ARW
$10.6B
$2.06M 0.26%
+9,637
New +$1.92M
2026 Q2
0 quarters
TRST icon
107
Trustco Bank Corp NY
TRST
$958M
$2.05M 0.26%
37,380
– –
2020 Q2
24 quarters
NMRK icon
108
Newmark Group
NMRK
$2.09B
$2.05M 0.26%
135,726
-715
-0.5% -$10.9K
2025 Q4
2 quarters
EBS icon
109
Emergent Biosolutions
EBS
$349M
$2.02M 0.26%
241,298
– –
2025 Q3
3 quarters
HSTM icon
110
HealthStream
HSTM
$1.03B
$1.99M 0.25%
72,988
– –
2022 Q3
15 quarters
HBCP icon
111
Home Bancorp
HBCP
$477M
$1.96M 0.25%
28,628
+311
+1% +$20.1K
2021 Q1
21 quarters
COLL icon
112
Collegium Pharmaceutical
COLL
$775M
$1.92M 0.24%
52,911
-44
-0.1% -$1.5K
2019 Q2
28 quarters
DAKT icon
113
Daktronics
DAKT
$907M
$1.91M 0.24%
97,502
– –
2023 Q4
10 quarters
GRDN icon
114
Guardian Pharmacy Services
GRDN
$2.58B
$1.86M 0.24%
44,354
– –
2025 Q4
2 quarters
ADTN icon
115
Adtran
ADTN
$532M
$1.84M 0.24%
132,526
+109
+0.1% +$1.7K
2025 Q3
3 quarters
KFRC icon
116
Kforce
KFRC
$1.03B
$1.81M 0.23%
38,632
– –
2017 Q1
37 quarters
QCRH icon
117
QCR Holdings
QCRH
$1.66B
$1.77M 0.23%
18,154
– –
2020 Q1
25 quarters
ATRO icon
118
Astronics
ATRO
$2.55B
$1.75M 0.22%
21,590
-4,318
-17% -$295K
2025 Q2
4 quarters
EPAM icon
119
EPAM Systems
EPAM
$7.25B
$1.75M 0.22%
22,089
– –
2024 Q4
6 quarters
KALU icon
120
Kaiser Aluminum
KALU
$1.9B
$1.74M 0.22%
+8,903
New +$1.51M
2026 Q2
0 quarters
ARLO icon
121
Arlo Technologies
ARLO
$1.56B
$1.73M 0.22%
128,094
– –
2024 Q1
9 quarters
ADUS icon
122
Addus HomeCare
ADUS
$2.34B
$1.64M 0.21%
16,275
-513
-3% -$48.4K
2013 Q2
52 quarters
FSTR icon
123
Foster
FSTR
$377M
$1.6M 0.2%
+35,448
New +$1.32M
2026 Q2
0 quarters
JKHY icon
124
Jack Henry & Associates
JKHY
$11.3B
$1.59M 0.2%
11,562
+981
+9% +$139K
2024 Q1
9 quarters
EME icon
125
Emcor
EME
$29.8B
$1.57M 0.2%
+1,894
New +$1.6M
2026 Q2
0 quarters

Similar funds

Globeflex Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Financials.

  • Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
  • Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
  • Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
  • Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
  • Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
  • Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
  • Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.